dermatologic agents

Summary

Summary: Drugs used to treat or prevent skin disorders or for the routine care of skin.

Top Publications

  1. ncbi A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting
    J de Korte
    Department of Dermatology, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Br J Dermatol 158:375-81. 2008
  2. ncbi The socioeconomic impact of atopic dermatitis in the United States: a systematic review
    Anthony J Mancini
    Division of Pediatric Dermatology, Children s Memorial Hospital, and Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614, USA
    Pediatr Dermatol 25:1-6. 2008
  3. ncbi Guidelines for treating acne
    Andreas D Katsambas
    Department of Dermatology, University of Athens, Andreas Sygros Hospital, 5 Ionos Dragoumi Street, Athens, Greece
    Clin Dermatol 22:439-44. 2004
  4. ncbi Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review
    Electra Nicolaidou
    First Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece
    J Am Acad Dermatol 60:470-7. 2009
  5. ncbi The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up
    H Zachariae
    Department of Dermatology, Marselisborg Hospital, Aarhus, Denmark
    Br J Dermatol 144:100-3. 2001
  6. ncbi Acne and systemic disease
    Margarita S Lolis
    Department of Dermatology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    Med Clin North Am 93:1161-81. 2009
  7. ncbi Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris
    Canan Gorpelioglu
    Department of Dermatology, Fatih University Faculty of Medicine, Ankara, Turkey
    Int J Dermatol 49:87-90. 2010
  8. ncbi Long-term mini-doses of isotretinoin in the treatment of relapsing acne
    Boaz Amichai
    J Dermatol 30:572. 2003
  9. ncbi Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
    J J Hoefnagel
    Department of Dermatology, B1-Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 149:363-9. 2003
  10. ncbi Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials
    Richard Shikiar
    Center for Health Outcomes Research, MEDTAP International, Inc, Seattle, WA USA
    Health Qual Life Outcomes 1:53. 2003

Research Grants

Detail Information

Publications212 found, 100 shown here

  1. ncbi A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting
    J de Korte
    Department of Dermatology, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Br J Dermatol 158:375-81. 2008
    ..Quality of life, i.e. the physical, psychological, and social functioning and well-being of the patient, has become an essential outcome measure in chronic skin disease...
  2. ncbi The socioeconomic impact of atopic dermatitis in the United States: a systematic review
    Anthony J Mancini
    Division of Pediatric Dermatology, Children s Memorial Hospital, and Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614, USA
    Pediatr Dermatol 25:1-6. 2008
    ..Measurement of the cost of atopic dermatitis in the United States has been limited to direct cost-identification analyses, with few studies measuring the indirect cost of disease...
  3. ncbi Guidelines for treating acne
    Andreas D Katsambas
    Department of Dermatology, University of Athens, Andreas Sygros Hospital, 5 Ionos Dragoumi Street, Athens, Greece
    Clin Dermatol 22:439-44. 2004
    ..3) Effective treatment can dramatically improve a person's quality of life...
  4. ncbi Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review
    Electra Nicolaidou
    First Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece
    J Am Acad Dermatol 60:470-7. 2009
    ..Available data concerning the follow-up of treated patients and some criteria for the selection of patients with a greater chance to respond satisfactorily to treatment are also presented...
  5. ncbi The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up
    H Zachariae
    Department of Dermatology, Marselisborg Hospital, Aarhus, Denmark
    Br J Dermatol 144:100-3. 2001
    ..Methotrexate (MTX) -induced liver damage is an important complication in patients treated with this drug for skin disease. Reliable non-invasive monitoring tests would have considerable importance...
  6. ncbi Acne and systemic disease
    Margarita S Lolis
    Department of Dermatology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    Med Clin North Am 93:1161-81. 2009
    ..Generally, the severity of acne lesions determines the type of acne regimen necessary. The emergence of drug-resistant P acnes and adverse side effects are current limitations to effective acne management...
  7. ncbi Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris
    Canan Gorpelioglu
    Department of Dermatology, Fatih University Faculty of Medicine, Ankara, Turkey
    Int J Dermatol 49:87-90. 2010
    ..Isotretinoin caused signs and symptoms of dry nose and disturbed mucociliary clearance without affecting PFTs. Nasal complications generally are not serious, especially when isotretinoin is taken in low doses...
  8. ncbi Long-term mini-doses of isotretinoin in the treatment of relapsing acne
    Boaz Amichai
    J Dermatol 30:572. 2003
  9. ncbi Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
    J J Hoefnagel
    Department of Dermatology, B1-Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 149:363-9. 2003
    ..CONCLUSIONS: The present study indicates that FAE can be considered as a safe long-term treatment in patients with severe psoriasis...
  10. ncbi Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials
    Richard Shikiar
    Center for Health Outcomes Research, MEDTAP International, Inc, Seattle, WA USA
    Health Qual Life Outcomes 1:53. 2003
    ..Patient reported measures of psoriasis-related functionality and health-related quality of life and of psoriasis-related symptom assessments were included as part of the trials...
  11. ncbi Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
    Vera M R Heydendael
    Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    N Engl J Med 349:658-65. 2003
    ..CONCLUSIONS: No significant differences in efficacy were found between methotrexate and cyclosporine for the treatment of moderate-to-severe psoriasis...
  12. ncbi The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study
    Katie O Fuchs
    Glens Falls Hospital, Glens Falls, New York 12801, USA
    Cutis 71:481-8. 2003
    ..Although not statistically significant (P = .1), a cumulative effect was seen when estradiol and glycolic acid creams were used in combination...
  13. ncbi Infliximab associated new-onset psoriasis
    David R Adams
    Penn State Hershey Medical Center, Department of Dermatology, Hershey, PA 17033, USA
    J Drugs Dermatol 5:178-9. 2006
    ..We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis...
  14. ncbi The long-term efficacy and safety of new biological therapies for psoriasis
    Kim A Papp
    Probity Medical Research, University of Western Ontario, 135 Union Street East, Waterloo, Ontario, Canada
    Arch Dermatol Res 298:7-15. 2006
    ..Long-term data from psoriasis trials continue to accumulate. Recent data suggest that biological therapies have efficacy and safety profiles suitable for the long-term treatment of patients with moderate to severe psoriasis...
  15. ncbi Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
    Gerald D Weinstein
    University of California, Irvine, USA
    J Am Acad Dermatol 48:760-7. 2003
    ..Tazarotene cream 0.1% was generally more effective, although slightly less well tolerated, than the 0.05% cream...
  16. ncbi Psoriasis
    Mark Lebwohl
    Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Lancet 361:1197-204. 2003
    ..Enhancements in topical therapy and phototherapy have also increased the armamentarium of treatments available for this disorder...
  17. ncbi Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression
    W H P M Vissers
    Department of Dermatology, Radboud University Medical Centre Nijmegen, René Descartes dreef 1, Nijmegen, The Netherlands
    Br J Dermatol 158:705-12. 2008
    ..g. the transcription of proinflammatory cytokines, keratinocyte hyperproliferation and the expression of HLA-DR in lesional psoriatic skin...
  18. ncbi The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial
    E M G J de Jong
    Department of Dermatology, University Hospital Center St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    Br J Dermatol 148:318-25. 2003
    ..A multicentre, randomized, double-blind, vehicle-controlled, parallel-group study was carried out to study the effect of the addition of calcipotriol ointment to methotrexate (MTX) therapy in patients with psoriasis vulgaris...
  19. ncbi Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial
    Charles N Ellis
    Department of Dermatology, University of Michigan Medical School, Ann Arbor 48109-0314, USA
    Am J Clin Dermatol 4:131-9. 2003
    ..CONCLUSIONS: The clinical effect of alefacept on psoriasis is associated with an improvement in patients' QOL. Among patients with moderate to severe psoriasis, an improvement in PASI of 50% or more is associated with better QOL scores...
  20. ncbi Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial
    Kenneth B Gordon
    Loyola University Medical Center, Maywood, Ill 60153, USA
    JAMA 290:3073-80. 2003
    ..Because T-cell interactions are involved in the pathophysiology of psoriasis, therapy with a T-cell modulator may have beneficial effects on psoriasis severity and health-related quality of life (HRQL)...
  21. ncbi Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    G P Aithal
    Queen s Medical Centre University Hospital, Nottingham, UK
    Aliment Pharmacol Ther 19:391-9. 2004
    ..Reports that up to 26% of subjects with psoriasis develop cirrhosis have led to a recommendation of serial liver biopsies after each cumulative dose of 1500 mg of methotrexate...
  22. ncbi Low-dose schema of isotretinoin in acne vulgaris
    I Mandekou-Lefaki
    State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece
    Int J Clin Pharmacol Res 23:41-6. 2003
    ..Our results confirm the beneficial effect of the low-dose schema. We recommend a total dose > or = 120 mg/kg, as this therapeutic regimen of isotretinoin has proven to be the most successful in preventing relapses and scarring...
  23. ncbi A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation
    J E M Körver
    Department of Dermatology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands
    Br J Dermatol 156:130-7. 2007
    ..However, studies comparing both treatment modalities are scarce. Especially, there are almost no studies comparing the effects on epidermal cell populations in a quantitative manner...
  24. ncbi A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy
    S C Kellett
    Department of Clinical Psychology, Keresforth Centre, Barnsley S70 6RS, UK
    Eur J Dermatol 15:484-8. 2005
    ..Corresponding improvements in the somatic symptoms of depression and hopelessness were not found. The implications of the research are discussed in relation to methodological design issues in this area...
  25. ncbi Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis
    Francesca Chamian
    Laboratory for Investigative Dermatology, The Rockefeller University, New York, USA
    J Transl Med 5:27. 2007
    ..Alefacept (anti-CD2) biological therapy selectively targets effector memory T cells (Tem) in psoriasis vulgaris, a model Type 1 autoimmune disease...
  26. ncbi Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes
    Vaibhav Dubey
    Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr Hari Singh Gour University, Sagar M P, 470003, India
    J Control Release 123:148-54. 2007
    ..Our results suggests that ethosomes are an efficient carrier for dermal and transdermal delivery of MTX...
  27. ncbi Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks
    L Naldi
    Clinica Dermatologica, Ospedali Riuniti, Largo Barozzi, 1 24128 Bergamo, Italy
    Br J Dermatol 152:597-615. 2005
    ..This review summarizes the benefits and risks of traditional, nonbiological therapies for moderate to severe chronic plaque psoriasis...
  28. ncbi Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial
    Craig L Leonardi
    Saint Louis University School of Medicine, St Louis, Missouri, USA
    J Am Acad Dermatol 52:425-33. 2005
    ..Efalizumab inhibits multiple T-cell-mediated processes...
  29. ncbi A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage
    Sewon Kang
    University of Michigan Medical Center, Department of Dermatology, Ann Arbor, Michigan 48109 0314, USA
    J Am Acad Dermatol 52:268-74. 2005
    ..Previous studies indicate that tazarotene is efficacious in reducing signs of photodamage. Objective We sought to confirm the efficacy and tolerability of tazarotene 0.1% cream in the treatment of facial photodamage...
  30. ncbi 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro
    Kally C O'Reilly
    Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA
    Exp Biol Med (Maywood) 232:1195-203. 2007
    ..Increases in both 5-HT(1A) receptor and SERT proteins may lead to decreased serotonin availability at synapses. Such an effect of 13-cis-RA could contribute to the increased depression-related behaviors we have shown in mice...
  31. ncbi Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study
    Nicholas Lowe
    Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, USA
    J Cosmet Laser Ther 6:79-85. 2004
    ..To compare the efficacy and tolerability of tazarotene 0.1% cream and tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin...
  32. ncbi Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
    Brian J Nickoloff
    Skin Disease Research Laboratory and Cardinal Bernardin Cancer Center, Loyola University of Chicago, Medical Center, Maywood, Illinois 60153, USA
    J Clin Invest 113:1664-75. 2004
    ..Such strategic transition from serendipity to the use of novel selective agents aimed at defined targets in psoriatic lesions is moving rapidly from research benches to the bedsides of patients with this chronic and debilitating disease...
  33. ncbi Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression
    S Benoit
    Department of Dermatology, , Josef-Schneider-Str. 2, 97080 Wuerzburg, Germany
    Br J Dermatol 150:1009-12. 2004
    ..We conclude that anti-TNF-alpha treatment with infliximab is an effective therapy in severe pustular psoriasis which is reflected by downregulation of disease-promoting chemokines such as IL-8, Gro-alpha and MCP-1...
  34. ncbi Practical use of Juvéderm: early experience
    Kevin C Smith
    Niagara Falls Dermatology and Skin Care Center, Ontario, Canada
    Plast Reconstr Surg 120:67S-73S. 2007
    ..The author's purpose was to provide early information to clinicians who perform aesthetic surgery...
  35. ncbi Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study
    Laurent Azoulay
    Department of Pharmacy, University of Montreal, Quebec, Canada
    J Clin Psychiatry 69:526-32. 2008
    ..To determine whether isotretinoin increases the risk of depression in patients with acne vulgaris...
  36. ncbi 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat
    Junko Ishikawa
    Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1 1 1 Minamikogushi, Ube, Yamaguchi 755 8505, Japan
    Eur J Neurosci 27:2363-72. 2008
    ..Moreover, RXR has a greater influence on the morphology of 5-HT neurons than RAR. The receptor-mediated actions of 13-cis-RA presented here may provide a clue for further research on depression associated with the use of 13-cis-RA...
  37. ncbi Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study
    U Mrowietz
    Department of Dermatology, University of Kiel, Germany
    Br J Dermatol 138:456-60. 1998
    ..Transient eosinophilia seems to be a characteristic feature of FAE therapy, while lymphocytopenia is usually mild. Adverse effects are dose-related and consist mainly of gastrointestinal complaints and flushing...
  38. ncbi Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury
    G Langman
    Department of Anatomical Pathology, Groote Schuur Hospital and the University of Cape Town, South Africa
    J Gastroenterol Hepatol 16:1395-401. 2001
    ..In addition, MTX alone can cause a NASH-like pattern of injury that is at least, in part, caused by a higher cumulative dose...
  39. ncbi Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily f
    S Kang
    Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    Arch Dermatol 137:1597-604. 2001
    ..To assess the safety and efficacy of 4 concentrations of tazarotene cream in the treatment of facial photodamage...
  40. ncbi Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne
    H P Gollnick
    Department of Dermatology and Venerology, Otto von Guericke University, Magdeburg, Germany
    Eur J Dermatol 11:538-44. 2001
    ..The secondary aim was to establish the value of AA cream as maintenance therapy in the prevention of recurrent acne...
  41. ncbi Topical therapies for localized psoriasis
    P M Witman
    Department of Dermatology, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 76:943-9. 2001
    ..This article reviews the topical medications currently available for the treatment of psoriasis and provides an approach to patients with localized disease...
  42. ncbi Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial
    S Reitamo
    Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, Meilahdentie 2, 00250 Helsinki, Finland
    Br J Dermatol 145:438-45. 2001
    ..The identification of a highly potent immunosuppressive/antiproliferative agent with an acceptable toxicity profile has long been a goal for the management of severe plaque psoriasis...
  43. ncbi Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions
    M J Alvarez-Figueroa
    Departamento de Farmacia y Tecnologia Farmaceutica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15706, Santiago de Compostela, Spain
    Int J Pharm 215:57-65. 2001
    ..At the end of all assays, significant amounts of MTX were detected in the skin. These results suggest that both hydrogels and microemulsions may be of value for the topical administration of MTX in the treatment of psoriasis...
  44. ncbi Combination therapy with vitamin D analogues
    S Lamba
    Department of Dermatology, Mount Sinai Medical Center, New York 10029-6574, USA
    Br J Dermatol 144:27-32. 2001
    ..As long as treatments are used correctly, the benefits of combination therapy with vitamin D analogues usually outweigh the few drawbacks...
  45. ncbi Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice
    Kally C O'Reilly
    Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA
    Eur J Pharmacol 605:68-77. 2009
    ....
  46. ncbi Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients
    Bong Jin Hahm
    Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
    J Dermatol 36:255-61. 2009
    ..These results indicate that oral isotretinoin therapy alleviates depressive symptoms. Improvements in depression are directly related to acne-related life quality improvements rather than to improvement in acne grade...
  47. ncbi Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study
    J Ring
    University Hospital of Dermatology, Hamburg, Germany
    Br J Dermatol 144:495-9. 2001
    ..CONCLUSIONS: Calcitriol 3 microg g-1 ointment and UVB phototherapy in combination provides a promising therapy for managing chronic plaque psoriasis...
  48. ncbi A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis
    L C Guenther
    Private practice and University of Western Ontario, London, Canada
    Clin Ther 22:1225-38. 2000
    ..Tazarotene is commonly used in conjunction with a topical corticosteroid. In this study, tazarotene was used with mometasone furoate (a synthetic corticosteroid), and the 2-drug regimen was compared with calcipotriene monotherapy...
  49. ncbi Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide
    S S Jick
    Boston Collaborative Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421, USA
    Arch Dermatol 136:1231-6. 2000
    ..It has been suggested that there is a causal association between isotretinoin therapy and the risk of depression, psychotic symptoms, suicide, and attempted suicide...
  50. ncbi Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel
    J Sefton
    Allergan, Inc, Irvine, and the Department of Dermatology, University of Pennsylvania College of Medicine, Philadelphia, Pennsylvania, USA
    J Am Acad Dermatol 43:656-63. 2000
    ..Tazarotene, a potent acetylenic retinoid for topical use, might be expected to benefit photodamaged skin, including improving the classical signs of fine wrinkles, mottled hyperpigmentation, and roughness...
  51. ncbi Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group
    C A Ramsay
    Women s College Hospital, University of Toronto, Canada
    Dermatology 200:17-24. 2000
    ..Although studies on calcipotriol and UVB have also been performed, there are no data on the UVB-saving effect of calcipotriol combined with broad-band UVB to reduce overall UVB exposure, while maintaining efficacy...
  52. ncbi Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab
    Rudolf E Schopf
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    J Am Acad Dermatol 46:886-91. 2002
    ..CONCLUSION: Although psoriasis tends to recur beyond 2 months of the infusions, this open study provides evidence that infliximab is an effective treatment...
  53. ncbi Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study
    Paul H Bowman
    Department of Dermatology, University of California at San Francisco, 94118, USA
    J Am Acad Dermatol 46:907-13. 2002
    ..There does not seem to be any chemical incompatibility between calcipotriene ointment and tazarotene gel that is clinically significant...
  54. ncbi Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin
    Marek Haftek
    Universite Lyon 1, EA4169 Laboratory for Dermatological Research, Edouard Herriot Hospital, Lyon, France
    Exp Dermatol 17:946-52. 2008
    ..Two-thirds of the subjects showed an improvement. The re-appearance of a normally structured elastic fibre network was observed. Our results revealed a functional and structural remodelling of chronically sun-damaged skin...
  55. ncbi Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
    D Rigopoulos
    Department of Dermatology, Nail Unit, University of Athens Medical School, A Sygros Hospital, Athens, Greece
    Br J Dermatol 159:453-6. 2008
    ..Objectives The objective of this unblended, nonrandomized, open-label study was to evaluate the efficacy and safety of infliximab on nail psoriasis...
  56. ncbi Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial
    Tania J Phillips
    Boston University School of Medicine, Boston, MA 02118, USA
    Arch Dermatol 138:1486-93. 2002
    ..To determine the efficacy and safety of 0.1% tazarotene cream for the treatment of photodamage...
  57. ncbi Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis
    A Monastirli
    Department of Dermatology, School of Medicine, University of Patras, Patras, Greece
    Skin Pharmacol Appl Skin Physiol 15:246-51. 2002
    ....
  58. ncbi Recalcitrant, generalized pustular psoriasis: rapid and lasting therapeutic response to antitumour necrosis factor-alpha antibody (infliximab)
    K Schmick
    Br J Dermatol 150:367. 2004
  59. ncbi Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris
    H Gollnick
    Department of Dermatology and Venereology, Otto von Guericke University, Magdeburg, Germany
    Dermatology 205:46-53. 2002
    ..Calcipotriol is an established topical therapy for psoriasis vulgaris...
  60. ncbi Development of SLNs from natural lipids: application to topical delivery of tretinoin
    Sagar D Mandawgade
    Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, Maharashtra, India
    Int J Pharm 363:132-8. 2008
    ..The results of the characterization and evaluation established the safety for use, suitability and compatibility of indigenous natural lipids as a novel excipient...
  61. ncbi A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris
    W S Douglas
    Department of Dermatology, Monklands Hospital, Lanarkshire, Scotland, UK
    Acta Derm Venereol 82:131-5. 2002
    ..It is safe to transfer patients from combination to calcipotriol, with maintenance of clinical effect...
  62. ncbi Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type
    Meggan R Newland
    Department of Dermatology and Cutaneous Surgery, University of Miami, 1444 NW 9th Avenue, Miami, FL 33136, USA
    Int J Dermatol 41:449-52. 2002
    ..We report a case of rapid response and clinical benefit using infliximab in severe pustular psoriasis of von Zumbusch...
  63. ncbi Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study
    D Thaci
    Department of Dermatology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Dermatology 205:383-8. 2002
    ..Body-weight-dependent (BWD) treatment of psoriasis with cyclosporine A (CsA is well established. It has recently been reported that this is not necessary for the treatment of atopic dermatitis...
  64. ncbi Clobetasol propionate for psoriasis: are ointments really more potent?
    Lindsey Warino
    Ohio State University College of Medicine, School of Public Health, Columbus, OH, USA
    J Drugs Dermatol 5:527-32. 2006
    ..We excluded studies conducted before 1980 and those that allowed concomitant treatments...
  65. ncbi Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study
    Arnd Jacobi
    Department of Dermatology, University Hospital Marburg, Marburg, Germany
    Dermatology 216:133-6. 2008
    ..Facial psoriasis requires a treatment approach other than topical corticosteroids which bear the risk of skin atrophy. Topical pimecrolimus has been shown to be effective in atopic eczema and recently in psoriasis...
  66. ncbi Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study
    Colin Buckley
    Department of Dermatology, Waterford Regional Hospital Ardkeen, Waterford, Ireland
    Dermatology 217:107-13. 2008
    ..There is a need for more effective therapy for scalp psoriasis...
  67. ncbi [Is the psoriasis plaque test still relevant in the age of biologicals?]
    G Wozel
    Klinik und Poliklinik fur Dermatologie, Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden, Fetscherstrasse 74, 01307, Dresden
    Hautarzt 57:672-8. 2006
    ..The PPT is relatively simple, not time-consuming and allows the simultaneous testing of multiple substance. All the results from PPT must be confirmed by controlled clinical trials...
  68. ncbi Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment
    Corrie Rogers
    Phototherapy Education and Research Centre, Women's College Hospital, Toronto, Ontario, Canada
    Dermatol Nurs 18:258-61. 2006
    ..Light therapy was increased by 10% increments at each visit or as tolerated by the patient. Results show the combination of light therapy plus Dovobet may be an effective and convenient option in the treatment of psoriasis...
  69. ncbi Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris
    Reiko Noborio
    Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    Photodermatol Photoimmunol Photomed 22:262-4. 2006
    ..These findings provide further evidence that calcipotriol has advantages over maxacalcitol regarding the narrow-band UVB-accumulated treatment dose and improvement rate of psoriasis area and severity index (PASI) scores...
  70. ncbi [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs]
    J Schmitt
    , Fetscherstrasse 74, 01307, Dresden
    Hautarzt 57:679-84. 2006
    ..This also holds true for combinations with a UVB or UVA light therapy. Preparations containing both a corticosteroid and vitamin D derivative are well suited for combining topical treatment with modern systemic antipsoriatic drugs...
  71. ncbi Improved clinical outcomes with moisturization in dermatologic disease
    Fred E Ghali
    Pediatric Dermatology of North Texas, PA, Grapevine, USA
    Cutis 76:13-8. 2005
    ..Although further research is warranted, moisturizers represent a valuable first-line treatment option for many dermatologic diseases and confer a number of important therapeutic benefits beyond mere cosmetic effects...
  72. ncbi Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization
    H Jorn Bovenschen
    Radboud University Nijmegen Medical Centre, Rene Descartesdreef 1, 6525 GL, Nijmeger, The Netherlands
    J Dermatolog Treat 18:32-9. 2007
    ..Selective photothermolysis of diseased capillaries by pulsed dye laser (PDL) treatment has been described as a mechanism for long-lasting clearance of psoriatic plaques...
  73. ncbi Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris
    Mark G Lebwohl
    Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
    Cutis 79:3-4. 2007
  74. ncbi An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis
    X Zhu
    Department of Dermatology, Peking University First Hospital, Beijing, China
    J Eur Acad Dermatol Venereol 21:466-72. 2007
    ..Calcitriol and calcipotriol, two vitamin D derivatives, are available for topical treatment of psoriasis and have been shown to be effective...
  75. ncbi The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis
    Mark Lebwohl
    Mount Sinai School of Medicine, New York, New York, USA
    Cutis 80:29-40. 2007
    ..It is notable that in subjects who were being treated with a variety of agents, the addition of clobetasol propionate spray 0.05% during the course of the study resulted in improvements in disease severity...
  76. ncbi A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial
    Gregor B E Jemec
    Department of Dermatology, Health Sciences Faculty University of Copenhagen, Roskilde Hospital, Roskilde, Denmark
    J Am Acad Dermatol 59:455-63. 2008
    ..New topical treatments in scalp psoriasis are needed because many current topical treatments are disliked by patients and associated with poor compliance...
  77. ncbi Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment
    Gerald S Braun
    Int J Dermatol 46:1315-7. 2007
  78. ncbi Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure
    Yuka Adachi
    Department of Dermatology, Kanssai Medical University, Osaka, Japan
    Photodermatol Photoimmunol Photomed 24:16-8. 2008
    ..Experimental investigations demonstrated that calcipotriol is degraded by UV radiation, and suggested that calcipotriol should be applied after phototherapy but not immediately before...
  79. ncbi Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial
    Rosita Saraceno
    Department of Dermatology, University of Rome Tor Vergata, Viale Oxford 81, Rome, Italy
    J Dermatolog Treat 18:361-5. 2007
    ....
  80. ncbi Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years
    Anna Zampetti
    Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
    J Dermatolog Treat 19:134-40. 2008
    ..Psoriasis requires lifelong treatments that depend on the extent, clinical forms and associated conditions...
  81. ncbi Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial
    Y H Liao
    Department of Dermatology, National Taiwan University Hospital, College of Medicine, National Taiwan University, 7, Chung Shan South Road, Taipei 100, Taiwan
    Br J Dermatol 157:1005-12. 2007
    ..Two nonsteroidal topical agents, calcitriol and tacrolimus, have been reported to be effective and safe for psoriatic lesions on sensitive areas. However, no comparative studies between calcitriol and tacrolimus have been reported...
  82. ncbi Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate
    Dimitrios Sotiriadis
    First Dermatologic Clinic, Medical School, Aristotle University of Thessaloniki, Greece
    J Dermatolog Treat 18:315-8. 2007
    ..To investigate the efficacy of treating acrodermatitis continua of Hallopeau (ACH) with a new two-compound ointment...
  83. ncbi Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland
    Julia M Bottomley
    Amygdala Ltd, Letchworth Garden City, UK
    Curr Med Res Opin 23:1887-901. 2007
    ..To determine the cost-effectiveness of calcipotriol/betamethasone dipropionate (Dovobet) in the initial treatment of moderate severity plaque psoriasis vulgaris in Scotland...
  84. ncbi Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study
    Joe S Angelo
    Department of Dermatology, SLR and TC, Karigiri, Vellore, India
    Indian J Dermatol Venereol Leprol 73:65. 2007
    ..No controlled data is available till date comparing topical tazarotene and clobetasol in Indian psoriatic patients...
  85. ncbi Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas
    M G Lebwohl
    Department of Dermatology, The Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
    J Am Acad Dermatol 44:77-82. 2001
    ....
  86. ncbi Calcipotriol ointment versus cream in psoriasis vulgaris
    G Duweb
    Dermatology Department, Garyounis University, Benghazi, Libya
    Int J Clin Pharmacol Res 23:47-51. 2003
    ..In conclusion, calcipotriol was effective, safe and well tolerated in the treatment of psoriasis vulgaris and better results were observed with the ointment formulation. Longer treatment courses could be advised...
  87. ncbi Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients
    Jong-Hyun Rim
    Department of Dermatology, University Hospital, Seoul National University College of Medicine, 28-Yongon-dong, Chongno-gu, Seoul 110-744, Korea
    Photodermatol Photoimmunol Photomed 18:131-4. 2002
    ..More studies are warranted to confirm these results...
  88. ncbi Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis
    Vikas Sharma
    Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Int J Dermatol 42:834-8. 2003
    ..e. 12 weeks, 5% coal tar ointment had comparable efficacy. There was no statistically significant difference in the relapse rates between the two modalities...
  89. ncbi Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis
    Norito Katoh
    Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawara machi Hirokoji, Kamigyo ku, Kyoto 602 8566, Japan
    Eur J Dermatol 13:382-4. 2003
    ..The combined once-per-day application of 0.004% calcipotriol/0.01% clobetasol propionate as a premixed ointment is a promising regimen for psoriasis...
  90. ncbi Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis
    Morad Lahfa
    , 1 avenue Claude Vellefaux, 25015 Paris, France
    Eur J Dermatol 13:261-5. 2003
    ....
  91. ncbi Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients
    L Andreassi
    Clinica Dermatologica, University of Siena, Italy
    Br J Dermatol 148:134-8. 2003
    ..01). CONCLUSIONS: BVM is more effective than lotion-based ST commonly used in the treatment of scalp psoriasis, and has higher patient acceptability...
  92. ncbi Vitamin D and systemic therapy
    Peter van de Kerkhof
    Department of Dermatology, University Hospital, Nijmegen, Netherlands
    Cutis 70:16-20. 2002
    ....
  93. ncbi Vitamin D and topical therapy
    Mark Lebwohl
    Department of Dermatology, The Mount Sinai School of Medicine, New York, New York, USA
    Cutis 70:5-8. 2002
    ..05% ointment and cream have been shown to be compatible with calcipotriene for up to 2 weeks. The compatibility of calcipotriene and halobetasol permits the use of these agents together...
  94. ncbi Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris
    Yoshiki Miyachi
    Department of Dermatology, Kyoto University, Graduate School of Medicine, Kyoto, 606 8507, Japan
    Eur J Dermatol 12:463-8. 2002
    ..Serum calcium should be monitored in patients with decreased renal function and other suspected impairment of calcium metabolism, before and during the treatment with tacalcitol 20 microg/g ointment...
  95. ncbi The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures
    J E Osborne
    The Department of Dermatology, Leicester Royal Infirmary, UK
    J Eur Acad Dermatol Venereol 16:367-73. 2002
    ..0001). The frequency distribution of the PASI reduction defined responsive (70% of patients) and poorly responsive groups (30%), with mean PASI reduction of 60% and 17%, respectively...
  96. ncbi Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis
    Y Poulin
    Department of Dermatology, Centre Hospitalier Universitaire de Quebec, Canada
    Skin Therapy Lett 7:1-3. 2002
    ..This compound has been shown to be more active than either agent used along. The efficacy of once daily application was not shown to be different from that of twice daily use...
  97. ncbi Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream
    D Rigopoulos
    Acta Derm Venereol 82:140. 2002
  98. ncbi Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice
    J Lambert
    Department of Dermatology, University of Antwerp, Belgium
    Dermatology 204:321-4. 2002
    ..Various studies have shown the benefit of topical vitamin D(3) analogues in the treatment of mild to moderate plaque psoriasis...
  99. ncbi A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis
    S B Park
    Department of Dermatology, Seoul National University College of Medicine, Korea
    Pediatr Dermatol 16:321-5. 1999
    ..Therefore monitoring of vitamin D metabolites may be necessary during calcipotriol therapy. More investigative studies are needed to resolve this issue...
  100. ncbi Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches
    S Karrer
    Department of Dermatology, University of Regensburg, Germany
    Dermatology 202:108-15. 2001
    ....
  101. ncbi The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity
    C Queille-Roussel
    CPCAD, , BP 3079, 06202 Nice cedex, France
    Eur J Dermatol 11:219-24. 2001
    ..These studies showed that calcitriol 3 microg/g ointment is a well-tolerated treatment for stable plaque-type psoriasis...

Research Grants78

  1. ANALOG STUDIES OF 4-HPR AND ITS GLUCURONIDE
    Robert W Curley; Fiscal Year: 2010
    ..A clearer understanding of how these promising molecules function would further enhance our ability to develop and exploit them. ..
  2. ANALOG STUDIES OF 4-HPR AND ITS GLUCURONIDE
    ROBERT CURLEY; Fiscal Year: 2007
    ..for it to act; and identification of the primary target of 4-HPR action in cells and/or in vivo; 5) evaluation of our most potent analog (4-HPRCG or 4- HBRCG) with regard to tissue distribution and teratogenic potential ..
  3. ANALOG STUDIES OF 4-HPR AND ITS GLUCURONIDE
    ROBERT CURLEY; Fiscal Year: 2003
    ..abstract_text> ..
  4. ANALOG STUDIES OF 4-HPR AND ITS GLUCURONIDE
    ROBERT CURLEY; Fiscal Year: 2006
    ..abstract_text> ..
  5. ANALOG STUDIES OF RETINOID GLUCURONIDE ACTIVITY
    ROBERT CURLEY; Fiscal Year: 2001
    ....
  6. Regulation of Lipid Metabolism in Human Sebaceous Glands
    Diane Thiboutot; Fiscal Year: 2006
    ..Data generated from the proposed experiments will advance our understanding of the mechanisms regulating sebum production and can lead to identification of potential additional therapeutic target sites in the treatment of acne. ..
  7. Regulation of human sebaceous glands by 13-cis retinoic acid
    Diane Thiboutot; Fiscal Year: 2007
    ..The findings of these studies not only have the potential to advance our understanding of retinoid action in acne, but can lead to advances in the understanding of these agents in cancer biology and in innate immunity as well. ..
  8. Regulation of human sebaceous glands by 13-cis retinoic acid
    Diane M Thiboutot; Fiscal Year: 2010
    ..The findings of these studies not only have the potential to advance our understanding of retinoid action in acne, but can lead to advances in the understanding of these agents in cancer biology and in innate immunity as well. ..
  9. CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
    Sewon Kang; Fiscal Year: 2004
    ..abstract_text> ..
  10. Quantitating Absorption of Complex Chemical Mixtures
    Jim Riviere; Fiscal Year: 2007
    ..abstract_text> ..
  11. UV-induced collagen reduction: treating skin scleroderma
    Sewon Kang; Fiscal Year: 2005
    ....
  12. Quantitating Absorption of Complex Chemical Mixtures
    Jim Riviere; Fiscal Year: 2005
    ....
  13. Quantitating Absorption of Complex Chemical Mixtures
    Jim Riviere; Fiscal Year: 2009
    ..abstract_text> ..
  14. Regularity Mechanisms of Aldosterone Secretion
    Wendy Bollag; Fiscal Year: 2006
    ..The complex interactions between AngII and serum K+ levels suggest that abnormalities in the glomerulosa cell response to either agonist, or both, may contribute to the development of some forms of hypertension. ..
  15. PHOSPHOLIPASE D AND KERATINOCYTE DIFFERENTIATION
    Wendy Bollag; Fiscal Year: 2007
    ..abstract_text> ..
  16. Postprandial Vitamin A
    WILLIAM BLANER; Fiscal Year: 2007
    ..Here, we will focus on the roles that RBP, CRBPI, CRBPIII and lipoprotein lipase have in facilitating postprandial vitamin A incorporation into milk. ..
  17. Effect of tumor and heparan sulfate on immune responses
    Rashid Rashid; Fiscal Year: 2006
    ..Aim #3 will determine if in vivo heparan sulfate treatment of LLC-bearing mice can increase the Th1 response. Results of our studies will lead to more effective immunotherapeutic approaches for cancer treatment. ..
  18. Retinoids, RAMBAs, and Histone Deacetylase Inhibitors
    Vincent Njar; Fiscal Year: 2006
    ..The following specific aims that are proposed should enable us obtain substantial data that may support our hypothesis. ..
  19. Carotene Cleavage Enzyme: Properties and Physiology
    WILLIAM BLANER; Fiscal Year: 2007
    ..In Aim 4, we propose to use a cDNA clone for human CCE to characterize the biochemical properties of the recombinant enzyme. ..
  20. Vitamin A Storage and Metabolism
    WILLIAM BLANER; Fiscal Year: 2007
    ..Finally, in Aim 3 we will investigate how vitamin A is mobilized from HSCs and whether this requires direct involvement of serum retinol-binding protein (RBP) synthesized in hepatocytes. ..
  21. Postoperative dietary counseling after bariatric surgery
    DAVID SARWER; Fiscal Year: 2005
    ..Results of this study could have a significant impact on the postoperative care of these individuals. ..
  22. FASEB SUMMER RESEARCH CONFERENCE ON RETINOIDS
    WILLIAM BLANER; Fiscal Year: 2002
    ..This overview should allow the evaluation of future directions and the development of new ideas as well critical review of the recent research. ..
  23. THE PHOTOBIOLOGY OF VITAMIN D3
    Michael Holick; Fiscal Year: 1993
    ....
  24. Novel Optical System for Early Cervical Cancer Detection
    Roger McNichols; Fiscal Year: 2003
    ..Such a probe would be useful in detecting epithelial cancers in other easily accessible sites in the body including the urinary tract, bladder, gastro-intestinal tract, colon, and oral cavity. ..
  25. ORAL HEALTH OF OLDER TYPE 1 DIABETIC PATIENTS
    Paul Moore; Fiscal Year: 2003
    ..This overall plan will permit us to understand the etiology of these complications and to define specific subpopulations and risk factors appropriate for future prospective oral health prevention and intervention trials. ..
  26. Peripheral Nicotinic Cholinergic and Inflammatory Dysfunction in Aging
    Lorise C Gahring; Fiscal Year: 2010
    ..Further, we will determine if changes in nAChR expression shape the progression of normal aging of the skin through altering the important balance between normal and excessive inflammation. ..
  27. Cholinergic Modulation of Inflammatory CNS Cytokines
    LORISE GAHRING; Fiscal Year: 2006
    ..abstract_text> ..
  28. Peripheral Nicotinic Cholinergic and Inflammatory Dysfunction in Aging
    LORISE GAHRING; Fiscal Year: 2009
    ..Further, we will determine if changes in nAChR expression shape the progression of normal aging of the skin through altering the important balance between normal and excessive inflammation. ..
  29. Mechanisms of TNFa Enhancement of Nicotinic Receptor Upregulation
    LORISE GAHRING; Fiscal Year: 2009
    ..Understanding how the inflammatory system and response to nicotine interact will impact upon how we approach these problems with therapeutic agents. ..
  30. Peripheral Nicotinic Cholinergic and Inflammatory Dysfunction in Aging
    LORISE GAHRING; Fiscal Year: 2009
    ..Further, we will determine if changes in nAChR expression shape the progression of normal aging of the skin through altering the important balance between normal and excessive inflammation. ..
  31. Nicotine Modulation of Caspases in Non-Neuronal Cells
    LORISE GAHRING; Fiscal Year: 2006
    ....
  32. Cholinergic Modulation of Inflammatory CNS Cytokines
    LORISE GAHRING; Fiscal Year: 2003
    ....
  33. Neurocognitive Function in Childhood-Onset SLE (cSLE)
    Deborah Levy; Fiscal Year: 2007
    ..In assessing this neurocognitive impairment, we will elucidate risk factors to target in future treatment and prevention trials. ..
  34. SunSmart America: Evaluating a School-based Curriculum
    Robert Kirsner; Fiscal Year: 2007
    ..The results will be used for planning to implement the SunSmart America curriculum throughout Florida and nationwide. ..
  35. Mechanisms of TNFa Enhancement of Nicotinic Receptor Upregulation
    SCOTT WARREN ROGERS; Fiscal Year: 2010
    ..Understanding how the inflammatory system and response to nicotine interact will impact upon how we approach these problems with therapeutic agents. ..
  36. Phase I Clinical Trials of New Anticancer Agents
    Patricia LoRusso; Fiscal Year: 2007
    ....